Sign In
Buy PBI-PB
Pitney Bowes . Nt 43 Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | $0.427 |
| EPS actual | $0.470 |
| EPS Surprise | 10.15% |
| Revenue estimate | 471.827M |
| Revenue actual | 477M |
| Revenue Surprise | 1.10% |
| Release date | Feb 17, 2026 |
| EPS estimate | $0.376 |
| EPS actual | $0.450 |
| EPS Surprise | 19.78% |
| Revenue estimate | 483.555M |
| Revenue actual | 477.625M |
| Revenue Surprise | -1.23% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.315 |
| EPS actual | $0.305 |
| EPS Surprise | -3.17% |
| Revenue estimate | 467.445M |
| Revenue actual | 459.675M |
| Revenue Surprise | -1.66% |
| Release date | Jul 30, 2025 |
| EPS estimate | $0.275 |
| EPS actual | $0.166 |
| EPS Surprise | -39.78% |
| Revenue estimate | 475.917M |
| Revenue actual | 461.909M |
| Revenue Surprise | -2.94% |
Last 4 Quarters for Pitney Bowes . Nt 43
Below you can see how PBI-PB performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 30, 2025 |
| Price on release | $21.04 |
| EPS estimate | $0.275 |
| EPS actual | $0.166 |
| EPS surprise | -39.78% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $20.87 |
| Jul 25, 2025 | $20.72 |
| Jul 28, 2025 | $20.79 |
| Jul 29, 2025 | $20.83 |
| Jul 30, 2025 | $21.04 |
| Jul 31, 2025 | $21.12 |
| Aug 01, 2025 | $21.02 |
| Aug 04, 2025 | $21.13 |
| Aug 05, 2025 | $20.93 |
| 4 days before | 0.81% |
| 4 days after | -0.521% |
| On release day | 0.382% |
| Change in period | 0.287% |
| Release date | Oct 29, 2025 |
| Price on release | $19.38 |
| EPS estimate | $0.315 |
| EPS actual | $0.305 |
| EPS surprise | -3.17% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $19.28 |
| Oct 24, 2025 | $19.30 |
| Oct 27, 2025 | $19.34 |
| Oct 28, 2025 | $19.31 |
| Oct 29, 2025 | $19.38 |
| Oct 30, 2025 | $19.00 |
| Oct 31, 2025 | $18.93 |
| Nov 03, 2025 | $18.97 |
| Nov 04, 2025 | $19.04 |
| 4 days before | 0.519% |
| 4 days after | -1.75% |
| On release day | -1.96% |
| Change in period | -1.24% |
| Release date | Feb 17, 2026 |
| Price on release | $20.57 |
| EPS estimate | $0.376 |
| EPS actual | $0.450 |
| EPS surprise | 19.78% |
| Date | Price |
|---|---|
| Feb 10, 2026 | $20.45 |
| Feb 11, 2026 | $20.53 |
| Feb 12, 2026 | $20.41 |
| Feb 13, 2026 | $20.58 |
| Feb 17, 2026 | $20.57 |
| Feb 18, 2026 | $20.96 |
| Feb 19, 2026 | $20.93 |
| Feb 20, 2026 | $20.60 |
| Feb 23, 2026 | $20.50 |
| 4 days before | 0.587% |
| 4 days after | -0.340% |
| On release day | 1.90% |
| Change in period | 0.244% |
| Release date | May 05, 2026 |
| Price on release | $20.96 |
| EPS estimate | $0.427 |
| EPS actual | $0.470 |
| EPS surprise | 10.15% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $21.00 |
| Apr 30, 2026 | $21.01 |
| May 01, 2026 | $21.17 |
| May 04, 2026 | $21.05 |
| May 05, 2026 | $20.96 |
| May 06, 2026 | $20.77 |
| May 07, 2026 | $20.91 |
| May 08, 2026 | $21.29 |
| May 11, 2026 | $21.60 |
| 4 days before | -0.190% |
| 4 days after | 3.05% |
| On release day | -0.91% |
| Change in period | 2.86% |
Pitney Bowes . Nt 43 Earnings Call Transcript Summary of Q1 2026
Key points for investors: Pitney Bowes reported a strong, broad-based Q1 with results and momentum that supported raising guidance. SendTech showed signs of stabilization and improvement (meters decline slowing; shipping software bookings and paid subscriptions rising), with a focus on retention, predictive analytics, product simplification and leveraging the Pitney Bowes Bank as a competitive differentiator. Presort has stopped losses, is winning deals, and management is pursuing consolidation (advisers hired to accelerate tuck‑ins and evaluate opportunities). The Pitney Bowes Bank is making operational improvements and is viewed as an under‑leveraged strategic asset that can support customer financing and new growth initiatives. Free cash flow was notably strong ($43.5M) in Q1, driven by solid working capital management; management expressed confidence in the durability of free cash flow while remaining conservatively guided. Capital allocation has included dividend increases and significant share repurchases; management signaled a near‑term focus on deleveraging (target net debt/EBITDA around 3x) and expects to address 2027 maturities in the coming months without issuing new debt. Management also began a second stage strategic review with advisers. Risks and caveats called out: potential one‑time headwinds in SendTech from noncore customer volume declines, conservative treatment of pension adjustments tied to triggering events, and the usual macro and execution risks for consolidation and bank initiatives.
